Mednax Inc (MD) - Net Assets
Based on the latest financial reports, Mednax Inc (MD) has net assets worth $880.98 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.13 Billion) and total liabilities ($1.25 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check strategic asset allocation of Mednax Inc to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $880.98 Million |
| % of Total Assets | 41.35% |
| Annual Growth Rate | 13.72% |
| 5-Year Change | -3.44% |
| 10-Year Change | -68.64% |
| Growth Volatility | 57.65 |
Mednax Inc - Net Assets Trend (1994–2025)
This chart illustrates how Mednax Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see MD market cap overview.
Annual Net Assets for Mednax Inc (1994–2025)
The table below shows the annual net assets of Mednax Inc from 1994 to 2025. Also explore Mednax Inc equity growth rate to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $865.85 Million | +13.19% |
| 2024-12-31 | $764.94 Million | -9.91% |
| 2023-12-31 | $849.06 Million | -4.77% |
| 2022-12-31 | $891.63 Million | -0.56% |
| 2021-12-31 | $896.69 Million | +19.92% |
| 2020-12-31 | $747.72 Million | -50.12% |
| 2019-12-31 | $1.50 Billion | -51.46% |
| 2018-12-31 | $3.09 Billion | +0.70% |
| 2017-12-31 | $3.07 Billion | +11.07% |
| 2016-12-31 | $2.76 Billion | +13.25% |
| 2015-12-31 | $2.44 Billion | +7.60% |
| 2014-12-31 | $2.27 Billion | -3.30% |
| 2013-12-31 | $2.34 Billion | +15.11% |
| 2012-12-31 | $2.04 Billion | +17.58% |
| 2011-12-31 | $1.73 Billion | +19.59% |
| 2010-12-31 | $1.45 Billion | +21.62% |
| 2009-12-31 | $1.19 Billion | +23.31% |
| 2008-12-31 | $965.14 Million | +0.63% |
| 2007-12-31 | $959.05 Million | +10.77% |
| 2006-12-31 | $865.80 Million | +25.15% |
| 2005-12-31 | $691.79 Million | +21.15% |
| 2004-12-31 | $571.03 Million | -0.24% |
| 2003-12-31 | $572.38 Million | +4.45% |
| 2002-12-31 | $548.00 Million | +14.44% |
| 2001-12-31 | $478.85 Million | +97.95% |
| 2000-12-31 | $241.90 Million | +5.68% |
| 1999-12-31 | $228.90 Million | +10.37% |
| 1998-12-31 | $207.40 Million | +26.70% |
| 1997-12-31 | $163.70 Million | +20.10% |
| 1996-12-31 | $136.30 Million | +117.04% |
| 1995-12-31 | $62.80 Million | +290.06% |
| 1994-12-31 | $16.10 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Mednax Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 27817.3% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $830.00K | 0.10% |
| Other Comprehensive Income | $610.00K | 0.07% |
| Other Components | $947.57 Million | 109.44% |
| Total Equity | $865.85 Million | 100.00% |
Mednax Inc Competitors by Market Cap
The table below lists competitors of Mednax Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
V2X Inc
NYSE:VVX
|
$2.15 Billion |
|
Whirlpool Corporation
NYSE:WHR
|
$2.15 Billion |
|
Empresas Cablevisión S.A.B. de C.V
MX:CABLECPO
|
$2.15 Billion |
|
Foran Energy Group Co Ltd
SHE:002911
|
$2.15 Billion |
|
Alignment Healthcare LLC
NASDAQ:ALHC
|
$2.15 Billion |
|
Jiangxi Special Electric Motor Co Ltd
SHE:002176
|
$2.15 Billion |
|
LTC Properties Inc
NYSE:LTC
|
$2.15 Billion |
|
HeiLongJiang Kingland Technology Co Ltd
SHE:000711
|
$2.15 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mednax Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 764,938,000 to 865,854,000, a change of 100,916,000 (13.2%).
- Net income of 165,388,000 contributed positively to equity growth.
- Share repurchases of 86,683,000 reduced equity.
- New share issuances of 3,184,000 increased equity.
- Other comprehensive income increased equity by 1,681,000.
- Other factors increased equity by 17,346,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $165.39 Million | +19.1% |
| Share Repurchases | $86.68 Million | -10.01% |
| Share Issuances | $3.18 Million | +0.37% |
| Other Comprehensive Income | $1.68 Million | +0.19% |
| Other Changes | $17.35 Million | +2.0% |
| Total Change | $- | 13.19% |
Book Value vs Market Value Analysis
This analysis compares Mednax Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.63x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 86.28x to 2.63x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1994-12-31 | $0.31 | $26.69 | x |
| 1995-12-31 | $1.20 | $26.69 | x |
| 1996-12-31 | $1.17 | $26.69 | x |
| 1997-12-31 | $1.35 | $26.69 | x |
| 1998-12-31 | $3.14 | $26.69 | x |
| 1999-12-31 | $3.61 | $26.69 | x |
| 2000-12-31 | $3.77 | $26.69 | x |
| 2001-12-31 | $5.33 | $26.69 | x |
| 2002-12-31 | $5.14 | $26.69 | x |
| 2003-12-31 | $5.82 | $26.69 | x |
| 2004-12-31 | $6.19 | $26.69 | x |
| 2005-12-31 | $7.18 | $26.69 | x |
| 2006-12-31 | $8.77 | $26.69 | x |
| 2007-12-31 | $9.61 | $26.69 | x |
| 2008-12-31 | $10.23 | $26.69 | x |
| 2009-12-31 | $12.80 | $26.69 | x |
| 2010-12-31 | $15.21 | $26.69 | x |
| 2011-12-31 | $17.69 | $26.69 | x |
| 2012-12-31 | $20.35 | $26.69 | x |
| 2013-12-31 | $23.15 | $26.69 | x |
| 2014-12-31 | $22.68 | $26.69 | x |
| 2015-12-31 | $25.95 | $26.69 | x |
| 2016-12-31 | $29.46 | $26.69 | x |
| 2017-12-31 | $32.72 | $26.69 | x |
| 2018-12-31 | $33.71 | $26.69 | x |
| 2019-12-31 | $17.79 | $26.69 | x |
| 2020-12-31 | $8.73 | $26.69 | x |
| 2021-12-31 | $10.37 | $26.69 | x |
| 2022-12-31 | $10.60 | $26.69 | x |
| 2023-12-31 | $10.33 | $26.69 | x |
| 2024-12-31 | $9.18 | $26.69 | x |
| 2025-12-31 | $10.15 | $26.69 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mednax Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 19.10%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.64%
- • Asset Turnover: 0.85x
- • Equity Multiplier: 2.59x
- Recent ROE (19.10%) is above the historical average (4.55%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1994 | 33.54% | 16.46% | 1.62x | 1.26x | $3.79 Million |
| 1995 | 10.67% | 15.26% | 0.63x | 1.11x | $420.00K |
| 1996 | 9.61% | 16.21% | 0.51x | 1.17x | $-530.00K |
| 1997 | 12.77% | 16.21% | 0.65x | 1.20x | $4.53 Million |
| 1998 | 14.47% | 15.70% | 0.68x | 1.35x | $8.99 Million |
| 1999 | 10.92% | 11.01% | 0.68x | 1.46x | $2.11 Million |
| 2000 | 4.54% | 4.52% | 0.75x | 1.34x | $-13.20 Million |
| 2001 | 6.35% | 8.58% | 0.62x | 1.20x | $-17.46 Million |
| 2002 | 12.55% | 14.78% | 0.72x | 1.18x | $13.98 Million |
| 2003 | 14.73% | 15.30% | 0.77x | 1.25x | $27.09 Million |
| 2004 | 17.21% | 15.86% | 0.79x | 1.38x | $41.18 Million |
| 2005 | 12.87% | 12.84% | 0.77x | 1.30x | $19.86 Million |
| 2006 | 14.38% | 15.21% | 0.72x | 1.31x | $37.88 Million |
| 2007 | 14.88% | 15.55% | 0.70x | 1.36x | $46.82 Million |
| 2008 | 17.53% | 15.84% | 0.71x | 1.55x | $72.69 Million |
| 2009 | 14.77% | 13.65% | 0.76x | 1.42x | $56.79 Million |
| 2010 | 14.00% | 14.46% | 0.69x | 1.41x | $57.95 Million |
| 2011 | 12.59% | 13.73% | 0.70x | 1.31x | $44.90 Million |
| 2012 | 11.84% | 13.26% | 0.66x | 1.35x | $37.37 Million |
| 2013 | 11.97% | 13.02% | 0.71x | 1.30x | $46.22 Million |
| 2014 | 14.00% | 13.01% | 0.68x | 1.59x | $90.72 Million |
| 2015 | 13.80% | 12.10% | 0.61x | 1.87x | $92.54 Million |
| 2016 | 11.77% | 10.21% | 0.60x | 1.93x | $48.84 Million |
| 2017 | 10.45% | 9.26% | 0.59x | 1.91x | $13.73 Million |
| 2018 | 8.70% | 7.37% | 0.61x | 1.92x | $-40.16 Million |
| 2019 | -99.91% | -84.15% | 0.43x | 2.77x | $-1.65 Billion |
| 2020 | -106.56% | -45.93% | 0.52x | 4.48x | $-871.24 Million |
| 2021 | 14.61% | 6.85% | 0.70x | 3.04x | $41.32 Million |
| 2022 | 7.44% | 3.36% | 0.84x | 2.63x | $-22.83 Million |
| 2023 | -7.11% | -3.03% | 0.90x | 2.61x | $-145.31 Million |
| 2024 | -12.95% | -4.92% | 0.94x | 2.81x | $-175.56 Million |
| 2025 | 19.10% | 8.64% | 0.85x | 2.59x | $78.80 Million |
Industry Comparison
This section compares Mednax Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $468,452,981
- Average return on equity (ROE) among peers: 4.90%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mednax Inc (MD) | $880.98 Million | 33.54% | 1.42x | $2.15 Billion |
| Acadia Healthcare Company Inc (ACHC) | $1.69 Billion | 7.07% | 1.54x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $34.55 Million | 0.57% | 2.43x | $1.69 Billion |
| agilon health Inc (AGL) | $-284.73 Million | 0.00% | 0.00x | $1.55 Billion |
| Airsculpt Technologies Inc (AIRS) | $83.99 Million | -5.33% | 1.43x | $153.56 Million |
| Amedisys Inc (AMED) | $736.34 Million | 18.45% | 0.59x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $819.68 Million | 8.62% | 1.87x | $624.22 Million |
| American Shared Hospital Service (AMS) | $11.70 Million | 13.68% | 4.25x | $8.87 Million |
| American Oncology Network Inc. (AONC) | $70.71 Million | -7.84% | 4.30x | $325.24 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.52 Billion | 13.82% | 2.26x | $1.53 Billion |
| Astrana Health Inc (ASTH) | $-83.19K | 0.00% | 0.00x | $1.89 Billion |
About Mednax Inc
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners,… Read more